51.74
-1.33
(-2.51%)
Al cierre: January 30 at 4:00:00 PM EST
51.01
-0.73
(-1.41%)
Preapertura: 4:16:52 AM EST
Nómina de miembros de la gerencia
Los datos de la lista de personas con información privilegiada se derivan únicamente de los formularios 3 y 4 de los últimos 24 meses presentados ante la SEC.
| Persona o entidad | Transacción más reciente | Fecha | Acciones adquiridas a partir de la fecha de transacción |
|---|---|---|---|
| CHAUDHURI BHASKAR Director | Conversion of Exercise of derivative security | Jun 24, 2024 | 5,350 |
| CRANE ROSEMARY A Director | Conversion of Exercise of derivative security | Jun 24, 2024 | 5,350 |
| FARROW JEFFREY S Chief Financial Officer | Sale | Jun 18, 2024 | 18,136 |
| GOLDBERG ANDREW D Director | Conversion of Exercise of derivative security | Jun 24, 2024 | 6,350 |
| LIN ELIZABETH YEU Director | Conversion of Exercise of derivative security | Jun 24, 2024 | 33,256 |
| LINK WILLIAM J Director | Sale | Aug 12, 2024 | -- |
| MORRISON SCOTT WILLIAM CPA Director | Stock Gift | Sep 30, 2024 | 6,016 |
| MOTTIWALA AZIZ Officer | Sale | Mar 18, 2024 | 54,075 |
| NEERVANNAN SESHADRI Chief Operating Officer | Sale | Mar 18, 2024 | 64,767 |
| YARNO WENDY L Director | Conversion of Exercise of derivative security | Jun 24, 2024 | 10,350 |
Pizarras relacionadas
SWTX SpringWorks Therapeutics, Inc.
37.23
+1.94%
VERA Vera Therapeutics, Inc.
37.48
-1.19%
RNA Avidity Biosciences, Inc.
32.63
+2.22%
VRNA Verona Pharma plc
57.24
+4.40%
DAWN Day One Biopharmaceuticals, Inc.
12.86
-1.15%
JANX Janux Therapeutics, Inc.
44.79
+5.36%
SRRK Scholar Rock Holding Corporation
40.40
-5.08%
EWTX Edgewise Therapeutics, Inc.
28.00
-1.48%
NUVL Nuvalent, Inc.
87.75
+2.61%
AXSM Axsome Therapeutics, Inc.
108.85
+3.53%